Article By: SureDividendRead
Friday, April 28, 2017 10:01 AM EDT
Bristol-Myers has a low payout ratio, a high level of profitability, and a strong balance sheet. These are the ingredients that should allow the company to raise its future dividend increases, possibly in the mid-single digit range.
In this article: BMY
Article By: Marvin R ClarkRead
Thursday, April 27, 2017 11:33 PM EDT
Today brought a deluge of earnings.Google parent Alphabet posted a 29 percent rise in quarterly profit, driven by a surge in advertising on mobiles and its popular YouTube video service.
In this article: BMY, DPZ, F, KKR, LNKD, LUV, UPS, AMZN, GOOG, INTC, MSFT, SBUX, AAL, ABBV, GOOGL, CCV
Article By: Douglas GammonsRead
Thursday, April 27, 2017 5:25 PM EDT
The market has stalled a bit after the big breakout. This is starting to look like a rally up to the top of the range. Then again, we are in the middle of earnings and there is tons of news everyday.
Article By: Rambus ChartologyRead
Thursday, April 27, 2017 10:00 AM EDT
The US stock markets have been in a bull market since 2009 by any trading discipline. It has climbed the proverbial wall of worry which is needed to create such a dynamic bull market.
Premarket Biotech Digest – ANTM May Increase Premium, IPXL Receives FDA Approval, ZTS Receives EC Nod
Article By: KKD Healthcare AnalyticsRead
Thursday, April 27, 2017 7:20 AM EDT
Impax Laboratories announced receiving the FDA approval for its its generic version of cholesterol drug Vytorin. Anthem said that its premium may increase by 20 percent or more pursuant to the loss of federal subsidies supporting Obamacare plans.
Article By: Dr. DuruRead
Thursday, April 27, 2017 3:24 AM EDT
The S&P 500 fell just short of 2,400 before fading to a flat close. If buyers do not step back in quickly, the index will risk a full retreat to 50DMA support (where I will happily reload on S&P 500 longs).
Article By: Lorimer WilsonRead
Wednesday, April 26, 2017 5:42 PM EDT
Amgen, Inc. Wednesday posted mixed first quarter earnings and lifted the low end of its 2017 profit outlook, as it continues to struggle to produce meaningful revenue gains amid a harsh regulatory environment.
In this article: AMGN
Article By: TickerTVRead
Wednesday, April 26, 2017 8:45 AM EDT
AKBA opened trading yesterday at $9.38 which was up from the previous day’s trading close of $9.31. Shares closed trading yesterday at $9.37 and spiked up after market to $12.25, equivalent to a 31% increase from the closing price.
In this article: AKBA